109 related articles for article (PubMed ID: 37734566)
1. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.
Tang J; Li J; Lian J; Huang Y; Zhang Y; Lu Y; Zhong G; Wang Y; Zhang Z; Bai X; Fang M; Wu L; Shen H; Wu J; Wang Y; Zhang L; Zhang H
J Adv Res; 2023 Sep; ():. PubMed ID: 37734566
[TBL] [Abstract][Full Text] [Related]
2. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
[TBL] [Abstract][Full Text] [Related]
3. Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer.
Jian Y; Huang X; Fang L; Wang M; Liu Q; Xu H; Kong L; Chen X; Ouyang Y; Wang X; Wei W; Song L
J Exp Clin Cancer Res; 2021 Feb; 40(1):56. PubMed ID: 33541412
[TBL] [Abstract][Full Text] [Related]
4. CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.
Han S; Hao H; Han H; Xue D; Jiao Y; Xie Y; Xu Y; Huangfu L; Fu J; Wang S; Sun H; Li P; Zhou Q
Cells; 2022 Sep; 11(19):. PubMed ID: 36231027
[TBL] [Abstract][Full Text] [Related]
5. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
[TBL] [Abstract][Full Text] [Related]
6. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
Zhang H; Zheng J; Fu Y; Ling J; Liu Z; Lin X; Dong X; Sun Y; Tan T; Guo Z; Xie G
Breast Cancer Res Treat; 2023 Apr; 198(3):437-446. PubMed ID: 36797433
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
9. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH
Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924
[TBL] [Abstract][Full Text] [Related]
10. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Yin H; Li Z; Chen J; Hu X
J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
12. miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis.
Li Y; Li X
Clin Transl Oncol; 2022 Sep; 24(9):1764-1775. PubMed ID: 35471684
[TBL] [Abstract][Full Text] [Related]
13. Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis.
Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y
Redox Biol; 2021 Jul; 43():101993. PubMed ID: 33946018
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.
Yang W; Li J; Zhang M; Yu H; Zhuang Y; Zhao L; Ren L; Gong J; Bi H; Zeng L; Xue Y; Yang J; Zhao Y; Wang S; Gao S; Fu Z; Li D; Zhang J; Wang T; Shan M; Tang B; Li X
J Exp Clin Cancer Res; 2022 Feb; 41(1):67. PubMed ID: 35180863
[TBL] [Abstract][Full Text] [Related]
15. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer.
Song H; Luo Q; Deng X; Ji C; Li D; Munankarmy A; Jian W; Zhao J; Fang L
Exp Mol Med; 2019 Nov; 51(11):1-13. PubMed ID: 31748508
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
Front Oncol; 2020; 10():1108. PubMed ID: 32754442
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
[TBL] [Abstract][Full Text] [Related]
18. Deletion of
Meng Q; Wang L; Lv Y; Wu J; Shi W
Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
[No Abstract] [Full Text] [Related]
19. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
20. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.
He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X
Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
